Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

PCI

Use of imaging guidance during coronary interventions has doubled in recent years

New research, published in The American Journal of Cardiology, uncovers widespread variability in provider preference for image guidance during PCI. 

American Society of Echocardiography President David Wiener, MD, FASE, outlined is initiatives for the next year, calling for wider collaboration, sustaining the workforce and better engagement with members.

New ASE president outlines key initiatives in cardiac ultrasound

American Society of Echocardiography President David H. Wiener, MD, said one of his biggest goals is to help the group thrive in the face of ongoing workforce challenges. He also hopes to get new members involved.

Explainable AI spots more cancer on breast MRI

Explainable AI boosts breast cancer detection on MRI

Experts involved in the model's development are hopeful their take on explainable AI can reduce problematic false positive rates common in breast MRI. 

Lantheus

Lantheus set to close $750M acquisition of PET agent developer Life Molecular Imaging

LMI is the maker of Neuraceq, a globally approved F-18 positron emission tomography imaging agent used to detect beta-amyloid plaques in patients evaluated for Alzheimer’s. 

foot feet podiatry podiatrist

Doppler ultrasound offers accurate, accessible alternative for diagnosing peripheral artery disease

Experts believe the method could be easily integrated into clinical settings and improve screening for PAD.

Thumbnail

AI ups detection of small prostate lesions by nearly 20%

Many experts believe that artifcial intelligence could help address issues with reader variability on prostate MRIs. 

Ultromics EchoGo Amyloidosis artificial intelligence

AI-enhanced echocardiography improves early detection of cardiac amyloidosis

The first FDA-cleared AI model of its kind was found to be an accurate screening tool for cardiac amyloidosis.

AI algorithm that diagnoses depression from MRI scans gains key regulatory approval

Experts are hopeful the software can bring more objectivity to the diagnostic process by giving providers visual evidence of alterations in brain activity.